A team of researchers has profiled in unprecedented detail thousands of individual cells sampled from patients’ brain tumors. The findings, along with the methods developed to obtain those findings, represent a significant advance in cancer research.
Individual Candida albicans yeast strains in the human gut are as different from each other as the humans that carry them, and some C. albicans strains may damage the gut of patients with inflammatory bowel disease, according to a new study from researchers at Weill Cornell Medicine.
The collaborative nature of innovation was one of the key messages author Steven Johnson delivered during a campus visit Sept. 22, as a guest of the Milstein Program in Technology & Humanity.
Most patients with severe COVID who are put on ventilators regain consciousness after removal of respiratory support, but recovery may take weeks after the period of mechanical ventilation has ended, according to a new study.
In this Q&A, Dr. Roy Gulick of Weill Cornell Medicine breaks down the science underlying booster shots of COVID-19 vaccines and answers some frequently asked questions.
Wolchok, an internationally acclaimed medical oncologist, will lead a clinical enterprise dedicated to translating groundbreaking discoveries on the underlying causes of cancer into cutting-edge treatment approaches and personalized therapies to improve patient outcomes.
Cornell researchers created cell-size robots that can be powered and steered by ultrasound waves. Despite their tiny size, these micro-robotic swimmers could be a formidable new tool for targeted drug delivery.
Robust collaboration between community partners and Cornell has resulted in more than 2 million COVID-19 tests, saving lives throughout the Finger Lakes region.
While people from all groups reduced their social interactions, those with higher incomes made greater changes to their behavior, according to a new study co-authored by a Cornell researcher.
The discovery of an “Achilles’ heel” in a type of gut bacteria that causes intestinal inflammation in patients with Crohn’s disease may lead to more targeted therapies for the difficult-to-treat disease, researchers have found.